Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Ernexa Therapeutics (ERNA) over the last 16 years, with Q3 2025 value amounting to $179000.0.

  • Ernexa Therapeutics' Prepaid Assets fell 3584.23% to $179000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $179000.0, marking a year-over-year decrease of 3584.23%. This contributed to the annual value of $186000.0 for FY2024, which is 8836.77% down from last year.
  • Latest data reveals that Ernexa Therapeutics reported Prepaid Assets of $179000.0 as of Q3 2025, which was down 3584.23% from $323000.0 recorded in Q2 2025.
  • Ernexa Therapeutics' Prepaid Assets' 5-year high stood at $1.8 million during Q2 2022, with a 5-year trough of $137000.0 in Q1 2025.
  • Its 5-year average for Prepaid Assets is $852812.4, with a median of $736500.0 in 2023.
  • Per our database at Business Quant, Ernexa Therapeutics' Prepaid Assets soared by 82683.77% in 2021 and then plummeted by 8836.77% in 2024.
  • Ernexa Therapeutics' Prepaid Assets (Quarter) stood at $1.4 million in 2021, then decreased by 5.11% to $1.3 million in 2022, then increased by 24.53% to $1.6 million in 2023, then tumbled by 88.37% to $186000.0 in 2024, then decreased by 3.76% to $179000.0 in 2025.
  • Its last three reported values are $179000.0 in Q3 2025, $323000.0 for Q2 2025, and $137000.0 during Q1 2025.